Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Type I phosphotidylinosotol 4-phosphate 5-kinase γ regulates osteoclasts in a bifunctional manner.

Zhu T, Chappel JC, Hsu FF, Turk J, Aurora R, Hyrc K, De Camilli P, Broekelmann TJ, Mecham RP, Teitelbaum SL, Zou W.

J Biol Chem. 2013 Feb 22;288(8):5268-77. doi: 10.1074/jbc.M112.446054.

2.

Platelets lacking PIP5KIγ have normal integrin activation but impaired cytoskeletal-membrane integrity and adhesion.

Wang Y, Zhao L, Suzuki A, Lian L, Min SH, Wang Z, Litvinov RI, Stalker TJ, Yago T, Klopocki AG, Schmidtke DW, Yin H, Choi JK, McEver RP, Weisel JW, Hartwig JH, Abrams CS.

Blood. 2013 Apr 4;121(14):2743-52. doi: 10.1182/blood-2012-07-445205.

3.

Loss of PIP5KIgamma, unlike other PIP5KI isoforms, impairs the integrity of the membrane cytoskeleton in murine megakaryocytes.

Wang Y, Litvinov RI, Chen X, Bach TL, Lian L, Petrich BG, Monkley SJ, Kanaho Y, Critchley DR, Sasaki T, Birnbaum MJ, Weisel JW, Hartwig J, Abrams CS.

J Clin Invest. 2008 Feb;118(2):812-9. doi: 10.1172/JCI34239. Erratum in: J Clin Invest. 2009 Feb;119(2):421. Kanaho, Yasunori [added].

4.

Effects of isoform-selective phosphatidylinositol 3-kinase inhibitors on osteoclasts: actions on cytoskeletal organization, survival, and resorption.

Shugg RP, Thomson A, Tanabe N, Kashishian A, Steiner BH, Puri KD, Pereverzev A, Lannutti BJ, Jirik FR, Dixon SJ, Sims SM.

J Biol Chem. 2013 Dec 6;288(49):35346-57. doi: 10.1074/jbc.M113.507525.

5.
6.

Preferential localization of type I phosphatidylinositol 4-phosphate 5-kinase γ at the periactive zone of mouse photoreceptor ribbon synapses.

Sakagami H, Katsumata O, Hara Y, Tamaki H, Fukaya M.

Brain Res. 2014 Oct 24;1586:23-33. doi: 10.1016/j.brainres.2014.08.051.

PMID:
25152467
7.

Alternative NF-κB Regulates RANKL-Induced Osteoclast Differentiation and Mitochondrial Biogenesis via Independent Mechanisms.

Zeng R, Faccio R, Novack DV.

J Bone Miner Res. 2015 Dec;30(12):2287-99. doi: 10.1002/jbmr.2584.

8.

Type I phosphatidylinositol 4-phosphate 5-kinase γ is required for neuronal migration in the mouse developing cerebral cortex.

Hara Y, Fukaya M, Tamaki H, Sakagami H.

Eur J Neurosci. 2013 Sep;38(5):2659-71. doi: 10.1111/ejn.12286.

PMID:
23802628
9.
10.

Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12.

Kameda Y, Takahata M, Komatsu M, Mikuni S, Hatakeyama S, Shimizu T, Angata T, Kinjo M, Minami A, Iwasaki N.

J Bone Miner Res. 2013 Dec;28(12):2463-75. doi: 10.1002/jbmr.1989.

11.

Vinculin regulates osteoclast function.

Fukunaga T, Zou W, Warren JT, Teitelbaum SL.

J Biol Chem. 2014 May 9;289(19):13554-64. doi: 10.1074/jbc.M114.550731.

12.

Targeted disruption of ephrin B1 in cells of myeloid lineage increases osteoclast differentiation and bone resorption in mice.

Cheng S, Zhao SL, Nelson B, Kesavan C, Qin X, Wergedal J, Mohan S, Xing W.

PLoS One. 2012;7(3):e32887. doi: 10.1371/journal.pone.0032887.

13.

Loss of Cbl-PI3K interaction enhances osteoclast survival due to p21-Ras mediated PI3K activation independent of Cbl-b.

Adapala NS, Barbe MF, Tsygankov AY, Lorenzo JA, Sanjay A.

J Cell Biochem. 2014 Jul;115(7):1277-89. doi: 10.1002/jcb.24779.

14.

Regulation of osteoclasts by membrane-derived lipid mediators.

Oikawa T, Kuroda Y, Matsuo K.

Cell Mol Life Sci. 2013 Sep;70(18):3341-53. doi: 10.1007/s00018-012-1238-4. Review.

15.

Regulation of osteoclast differentiation and function by phosphate: potential role of osteoclasts in the skeletal abnormalities in hypophosphatemic conditions.

Hayashibara T, Hiraga T, Sugita A, Wang L, Hata K, Ooshima T, Yoneda T.

J Bone Miner Res. 2007 Nov;22(11):1743-51.

16.

The loss of Cbl-phosphatidylinositol 3-kinase interaction perturbs RANKL-mediated signaling, inhibiting bone resorption and promoting osteoclast survival.

Adapala NS, Barbe MF, Langdon WY, Nakamura MC, Tsygankov AY, Sanjay A.

J Biol Chem. 2010 Nov 19;285(47):36745-58. doi: 10.1074/jbc.M110.124628.

17.

Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.

Lotinun S, Kiviranta R, Matsubara T, Alzate JA, Neff L, Lüth A, Koskivirta I, Kleuser B, Vacher J, Vuorio E, Horne WC, Baron R.

J Clin Invest. 2013 Feb;123(2):666-81. doi: 10.1172/JCI64840.

18.

The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5.

Crockett JC, Schütze N, Tosh D, Jatzke S, Duthie A, Jakob F, Rogers MJ.

Endocrinology. 2007 Dec;148(12):5761-8.

PMID:
17823253
19.

Incorporation of RANKL promotes osteoclast formation and osteoclast activity on β-TCP ceramics.

Choy J, Albers CE, Siebenrock KA, Dolder S, Hofstetter W, Klenke FM.

Bone. 2014 Dec;69:80-8. doi: 10.1016/j.bone.2014.09.013.

PMID:
25245204
20.

Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorption.

Ha H, Shim KS, An H, Kim T, Ma JY.

BMC Complement Altern Med. 2013 May 21;13:112. doi: 10.1186/1472-6882-13-112.

Items per page

Supplemental Content

Support Center